Endothelial Cell and Neutrophil Activation in Untreated Intercritical Patients With Gout

REFERENCES

1. 1.↵
   1. Kim SY,
   2. Guevara JP,
   3. Kim KM,
   4. Choi HK,
   5. Heitjan DF,
   6. Albert DA.

   Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 2010;62:170-80.

   OpenUrlCrossRef
2. 2.↵
   1. Krasnokutsky S,
   2. Romero AG,
   3. Bang D, et al

   . Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein. Clin Rheumatol 2018;37:1903-11.

   OpenUrlPubMed
3. 3.↵
   1. Toprover M,
   2. Shah B,
   3. Oh C, et al

   . Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study. Arthritis Res Ther 2020;22:169.

   OpenUrlPubMed
4. 4.↵
   1. Garshick MS,
   2. Barrett TJ,
   3. Wechter T, et al

   . Inflammasome signaling and impaired vascular health in psoriasis. Arterioscler Thromb Vasc Biol 2019;39:787-98.

   OpenUrlPubMed
5. 5.↵
   1. Hamo CE,
   2. Schlamp F,
   3. Drenkova K, et al

   . Burden of cardiometabolic risk factors and vascular health. Am Heart J 2024;269:201-4.

   OpenUrlPubMed
6. 6.↵
   1. Talmor N,
   2. Pillinger MH,
   3. Xia Y,
   4. Leonard A,
   5. Curovic F,
   6. Shah B.

   Neutrophil activation and adhesiveness in coronary artery disease: results from the COLCHICINE-PCI Biomarker Substudy. J Am Heart Assoc 2024;13:e036701.

   OpenUrlPubMed
7. 7.↵
   1. Hou ZH,
   2. Lu B,
   3. Gao Y, et al

   . Matrix metalloproteinase-9 (MMP-9) and myeloperoxidase (MPO) levels in patients with nonobstructive coronary artery disease detected by coronary computed tomographic angiography. Acad Radiol 2013;20:25-31.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. de Lima JD,
   2. de Paula AGP,
   3. Yuasa BS, et al

   . Genetic and epigenetic regulation of the innate immune response to gout. Immunol Invest 2023;52:364-97.

   OpenUrlPubMed